section name header

Evidence summaries

Green and Black Tea for the Primary Prevention of Cardiovascular Disease

Green and black tea may have some benefits on blood pressure and lipid levels. Level of evidence: "C"

The quality of evidence is downgraded by study limitations (unclear allocation concealment), and by imprecise results (few patients).

Summary

A Cochrane review [Abstract] 1 included 11 studies with a total of 821 subjects. Seven studies examined a green tea intervention and 4 examined a black tea intervention. There were variations in the dosage and form (drink, tablets or capsules) of the black and green tea interventions, and the duration of the interventions ranged from 3 months to 6 months. No studies reported cardiovascular events.

Black tea was found to produce statistically significant reductions in LDL cholesterol (MD -0.43 mmol/L, 95% CI -0.56 to -0.31) and systolic blood pressure (SBP) (MD -1.85 mmHg, 95% CI -3.21 to -0.48. Diastolic blood pressure (DBP) did not decrease significantly (MD -1.27 mmHg, 95% CI -3.06 to 0.53) over 6 months. Green tea produced statistically significant reductions in total cholesterol (MD -0.62 mmol/L, 95% CI -0.77 to -0.46), LDL cholesterol (MD -0.64 mmol/L, 95% CI -0.77 to -0.52) and blood pressure (SBP: MD -3.18 mmHg, 95% CI -5.25 to -1.11; DBP: MD -3.42, 95% CI -4.54 to -2.30). When both tea types were analysed together they showed favourable effects on LDL cholesterol (MD -0.48 mmol/L, 95% CI -0.61 to -0.35) and blood pressure (SBP: MD -2.25 mmHg, 95% CI -3.39 to -1.11; DBP: MD -2.81 mmHg, 95% CI -3.77 to -1.86). Adverse events were measured in 5 studies and included a diagnosis of prostate cancer, hospitalisation for influenza, appendicitis and retinal detachment but these are unlikely to be directly attributable to the intervention.

Clinical comments

Note

Date of latest search:

    References

    • Hartley L, Flowers N, Holmes J et al. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;(6):CD009934. [PubMed]

Primary/Secondary Keywords